← Leaderboards
Aria Vaishnavi
University Of Utah
$1,168,436
Attributed
$1,168,436
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2018–25$250K$187.5K$125K$62.5K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,168,436 · 3
By mechanism
R00$740,877 · 1
K99$347,184 · 1
F32$80,375 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Utah
Same institution · by research overlap
- Nathan Michael Krah$300,331
- Daniel W Fults$1,990,371
- Lewis C Murtaugh$5,738,542
- Phaedra Ghazi$88,571
- Sunil Sharma$2,103,455
Others in their field
Other Emerging Leaders on “Targeted Treatment”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Leonard Freedman · Leidos Biomedical Research, Inc.$66,755,704
- Susan Abushakra · Alzheon, Inc.$47,265,244
Research focus
Targeted TreatmentGeneticMouse ModelSignal TransductionTumor ProgressionOncogenicMalignant Neoplasm Of LungMolecularOncogenesPredictive MarkerTumorTumor MarkersUnited StatesTreatment OutcomeExperimental ModelsMalignant - DescriptorDna Sequence AlterationMalignant NeoplasmsCessation Of LifeMutationLoss Of FunctionKras2 GeneLungBraf Gene
Grant awards (8)
Elucidating the role of support signaling in promoting minimal residual disease in mouse models of oncogene-driven lung cancer$249,000
R00 · FY2025 · CA · contact PI
Elucidating the role of support signaling in promoting minimal residual disease in mouse models of oncogene-driven lung cancer$242,877
R00 · FY2024 · CA · contact PI
Elucidating the role of support signaling in promoting minimal residual disease in mouse models of oncogene-driven lung cancer$249,000
R00 · FY2023 · CA · contact PI
Elucidating the role of support signaling in promoting minimal residual disease in mouse models of oncogene-driven lung cancer$115,728
K99 · FY2022 · CA · contact PI
Elucidating the role of support signaling in promoting minimal residual disease in mouse models of oncogene-driven lung cancer$115,728
K99 · FY2021 · CA · contact PI
Elucidating the role of support signaling in promoting minimal residual disease in mouse models of oncogene-driven lung cancer$115,728
K99 · FY2020 · CA · contact PI
Elucidating tumor progression factors in MAPK-driven lung cancers$22,093
F32 · FY2019 · CA · contact PI
Elucidating tumor progression factors in MAPK-driven lung cancers$58,282
F32 · FY2018 · CA · contact PI